It is a high-tech enterprise focusing on the research and development, production and sales of new Tibetan medicine
Tibet Qizheng Tibetan Medicine Co., Ltd. (hereinafter referred to as Qizheng Tibetan Medicine) is a large-scale Tibetan medicine production enterprise in China, mainly engaged in the research and development, production and sales of new Tibetan medicine, now has 16 wholly-owned and holding subsidiaries such as GMP pharmaceutical factory and GSP marketing company, with 73 drug approval numbers, covering cardiovascular and cerebrovascular, respiratory system, digestive system, genitourinary system, nervous system, musculoskeletal system, gynecological diseases and other fields of products, among which Qizheng pain relief plaster as the representative of the external painkiller drug series has been sold for many years It has ranked first in the sales of topical pain relievers in China for seven consecutive years, ranked first in the first OTC product list of traditional Chinese medicine and surgery, and ranked among the key brands of over-the-counter drugs.
Qizheng Tibetan Medicine focuses on the Tibetan medicine industry, is committed to the inheritance and innovation of traditional Tibetan medicine, creates the first brand in China's external pain relief market, and excavates the unique potential of plateau medicine in terms of safety, efficacy and quality, so that the products continue to enter the mainstream market and public medical institutions, and have a positive impact on human beings and society. After more than 10 years of development, it has explored a successful model of modern market transformation of Tibetan medicine for thousands of years, and has formed its own core advantages: excellent brand building, leading channel marketing, R&D and innovation to ensure new product reserves, rich Tibetan resources, detailed modern medical research, high-quality financial status and profound cultural heritage. Qizheng Tibetan Medicine has the first brand of external pain relief patch products in China. On August 28, 2009, Qizheng Tibetan Medicine issued A shares for the first time and was officially listed on the Shenzhen Stock Exchange.
The company's innovation on the basis of inheritance has been continuously recognized by the society, and the leading product of analgesic plaster has won: the second prize of the National Science and Technology Progress Award, the Geneva International Invention Gold Medal, the protected varieties of traditional Chinese medicine, and the national secret varieties; The company has won the first batch of national innovative enterprises, key high-tech enterprises of the National Torch Program, national enterprise technology center, and the implementation unit of key projects of the national "Eleventh Five-Year Plan" science and technology support plan, and the company has 98 patented technologies, including 77 invention patents, 9 exclusive varieties and 5 protected varieties of traditional Chinese medicine in 73 drug approval numbers.
Through the practice of the core values of "altruism for good, righteousness and industry", Qizheng Tibetan medicine has opened up the road of innovation and development of the Tibetan medicine industry, created a harmonious management model of national medicine enterprises, ranked 66th among the top 100 taxpayers of China's private enterprises in 2004, and has become a tax credit enterprise commended by the government for several consecutive years, and has driven the progress of the local economy through industrial development.
